This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02218/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02218/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02218/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02218/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02218/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02218
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB02218 n13:DB02218
dcterms:title
N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside
adms:identifier
n4:46507169 n7:AC1 n8:46936324 n9:1672 n10:DB02218
n5:IUPAC-Name
n6:271B48B3-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B48B9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B48B8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B48B5-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B48B6-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B48B7-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B48B1-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B48AF-363D-11E5-9242-09173F13E4C5 n6:271B48B2-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B48B0-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B48BF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B48C0-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B48BA-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B48BB-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B48BD-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B48BC-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B48BE-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B48C5-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B48C7-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B48C8-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B48C4-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B48C3-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B48C6-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B48B4-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B48C1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B48C2-363D-11E5-9242-09173F13E4C5